One of the most successful biotech companies at BioPark Regensburg is growing into a company of 60 employees and has alone a turnover of 4.5 Million €. After reaching the profit threshold and to handle its rapid growth more easily the company founded in 1999 is being transformed into an AG and is striving to enter the stock market on 23 May 2006 in Frankfurt.

As one of the first leaseholders of construction phase II, Wilden AG has been a part of the BioPark since the beginning of the year. So now the leader of technology in medical synthetic material systems is door to door with companies from the Life Sciences. Adjacent to the office spaces, a show room has been created to display portfolios demonstrating achievements in the areas of pharmaceuticals, diagnostics, medical technology and consumer healthcare.